Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Hongguang Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Myeloid Cell Leukemia Sequence 1 Protein, Apoptosis, Leukemia, Myeloid, Acute, Indoles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Mcl-1 is a main antiapoptotic protein in acute myeloid leukemia (AML) and is used as a target to develop inhibitors. Currently, potent Mcl-1 inhibitors primarily interact with the P2-P4 pockets of Mcl-1, but pharmacological modulation by targeting the P1 pocket is less explored. We designed a series of 1H-indole-2-carboxylic acid compounds as novel Mcl-1 inhibitors occupying the P1-P3 pockets and evaluated their Mcl-1 inhibition and apoptosis induction in AML cells. Two-dimensional 15N-HSQC spectroscopy indicated that 47 (Ki = 24 nM) bound to the BH3 binding groove, occupied the P1 pocket in Mcl-1, and formed interactions with Lys234 and Val249. 47 exhibited good microsomal stability and pharmacokinetic profiles, with low potential risk of cardiotoxicity. 47 inhibited tumor growth in HL-60 and THP-1 xenograft models with growth inhibition rate of 63.7% and 57.4%, respectively. Collectively, 47 represents a novel Mcl-1 inhibitor targeting the P1-P3 pockets with excellent antileukemia effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Shenyang Pharmaceutical University, Shenyang 110016, China.
ORCID-Profile: Yongkui Jing, Linxiang Zhao
Förderung
- Liaoning Revitalization Talents Program
- National Natural Science Foundation of China
Zitieren
APA
Deng, H., Zhang, J., Liu, L., Zhang, H., Han, Y., Wu, L., Jing, Y., Huang, M., & Zhao, L. (2024). Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00643
Vancouver
Deng H, Zhang J, Liu L, Zhang H, Han Y, Wu L, et al. Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00643
BibTeX
@article{Deng2024,
author = {Deng, Hongguang and Zhang, Jingyi and Liu, Liang and Zhang, Hong and Han, Yu and Wu, Linlin and Jing, Yongkui and Huang, Min and Zhao, Linxiang},
title = {Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H -indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00643}
}
EUVIMED